Ann: Atomo and Access Bio renegotiate supply agreements, page-11

yup, good call. Good and meh ann

- no guarantee that AT1 will be able to sell 20m kits (prof + self-test) in AU market, but so far it appears that sales are doing well from company updates and news articles. Nevertheless having confirmed kit supply is good + consumer self-test approval potential is gr8 too...considering AU is our backyard and all the approvals to date, company really has to show it can sell mucho quantities here. Actually moving 20m kits in a reluctant market like AU would be a gr8 boost for brand recognition and cashflow

- meh news because another OEM agreement is gone/didn't commercialise into a regular thing for AT1's platform. Despite its uniqueness + safety potential, AT1 is still square 1 for expanding its commercial biz. Onto waiting some more for these US + China opp mentioned....